Publication

GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity

Cell Reports 112466, 2023 [online ahead of print]. Falk S, Petersen J, Svendsen C, Romero-Leguizamón CR, Jørgensen SH, Krauth N, Ludwig MQ, Lundø K, Roostalu U, Skovbjerg G, Gurskov Nielsen DA, Ejdrup AL, Pers TH, Dmytriyeva O, Hecksher-Sørensen J, Gether U, Kohlmeier KA, Clemmensen C

Share this page

Resource Library

Related resources

Novel insight into the distribution of L-cells in the rat intestinal tract

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

Improving membrane binding as a design strategy for amphipathic peptide hormones: 2-helixvariants of PYY3-36

LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650